Javier Briones-Meijide

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Correction to: High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Correction to: High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Journal: Cancer gene therapy

Published: December 02, 2022

Precision medicine in chronic lymphatic leukemia: Cost-effectiveness analysis of the new targeted therapies.

Precision medicine in chronic lymphatic leukemia: Cost-effectiveness analysis of the new targeted therapies.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: October 02, 2022

High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Journal: Cancer gene therapy

Published: May 02, 2022

Chimeric antigen-receptor (CAR) T cells: The revolution of the cell and personalized therapy for cancer.

Chimeric antigen-receptor (CAR) T cells: The revolution of the cell and personalized therapy for cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: November 10, 2019

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

Journal: Journal of translational medicine

Published: March 16, 2017

A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

Journal: Journal of translational medicine

Published: April 05, 2016

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Journal: Haematologica

Published: July 03, 2014

Targeted therapy of BCL6-dependent diffuse large B-cell lymphomas by heat-shock protein 90 inhibition.

Targeted therapy of BCL6-dependent diffuse large B-cell lymphomas by heat-shock protein 90 inhibition.

Journal: Expert review of hematology

Published: November 19, 2010

Emerging therapies for B-cell non-Hodgkin lymphoma.

Emerging therapies for B-cell non-Hodgkin lymphoma.

Journal: Expert review of anticancer therapy

Published: September 19, 2009

Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.

Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.

Journal: Histopathology

Published: March 25, 2009

Therapeutic vaccines for non-Hodgkin B-cell lymphoma.

Therapeutic vaccines for non-Hodgkin B-cell lymphoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 18, 2008

Showing 1-11 of 11

Last Updated: 09/26/2026